Supramolecular Nitric Oxide Depot for Hypoxic Tumor Vessel Normalization and Radiosensitization

Cuihong Yang,Ganen Mu,Ying Zhang,Yang Gao,Wenxue Zhang,Jinjian Liu,Wenwen Zhang,Paiyun Li,Lijun Yang,Zhimou Yang,Jie Gao,Jianfeng Liu

DOI: https://doi.org/10.1002/adma.202202625

IF: 29.4

2022-07-31

Advanced Materials

Abstract:In cancer radiotherapy, the lack of fixed DNA damages by oxygen in hypoxic microenvironment of solid tumors often lead to severe radioresistance. Nitric oxide (NO) is a potent radiosensitizer that acts in two ways. It can directly react with the radical DNA thus fixes the damage. It also normalizes the abnormal tumor vessels, thereby increasing blood perfusion and oxygen supply. To achieve these functions, the dosage and duration of NO treatment need to be carefully controlled, otherwise it would lead to the exact opposite outcomes. However, a delivery method that fulfills both requirements is still lacking. We designed a NO depot for the control of NO releasing both over quantity and duration for hypoxic tumor vessel normalization and radiosensitization. In B16 tumor‐bearing mice, the depot could provide low dosage NO continuously and release large amount of NO immediately before irradiation for a short period of time. These two modes of treatment worked in synergy to reverse the radioresistance of B16 tumor more efficiently than releasing at single dosage. This article is protected by copyright. All rights reserved

materials science, multidisciplinary,chemistry, physical,physics, applied, condensed matter,nanoscience & nanotechnology